Erratum: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2024.1502267

IF: 5.2

2024-10-08

Frontiers in Microbiology

Abstract:This article is an erratum on: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

microbiology

What problem does this paper attempt to address?

Erratum: Endoplasmic reticulum aminopeptidase 1 is involved in anti-viral immune response of hepatitis B virus by trimming hepatitis B core antigen to generate 9-mers peptides

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2023.1273875

IF: 5.2

2023-08-18

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.829241.].

microbiology
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology
A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum

Jun-Fang Zhang,Hua-Long Xiong,Jia-Li Cao,Shao-Juan Wang,Xue-Ran Guo,Bi-Yun Lin,Ying Zhang,Jing-Hua Zhao,Ying-Bin Wang,Tian-Ying Zhang,Quan Yuan,Jun Zhang,Ning-Shao Xia

DOI: https://doi.org/10.7150/thno.72666

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.20047.].

medicine, research & experimental
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Yong-Zheng Zhang,Amir Zeb,Lu-Feng Cheng

DOI: https://doi.org/10.3389/fimmu.2023.1168774

IF: 7.3

2023-02-28

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1032819.].

immunology
Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2024.1516456

IF: 4.7

2024-11-06

Frontiers in Oncology

Abstract:This article is an erratum on: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

oncology
Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1261322

IF: 7.3

2023-07-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1067399.].

immunology
Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chenyang Jiang,Lisong Teng

2019-01-01

Abstract:[This corrects the article on p. 1674 in vol. 11, PMID: 31938268.].
Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2024.1443537

IF: 5.6

2024-06-22

Frontiers in Pharmacology

Abstract:This article is an erratum on: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

pharmacology & pharmacy
Corrigendum: Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease

DOI: https://doi.org/10.14218/jcth.2022.00425

2022-09-30

Journal of Clinical and Translational Hepatology

Abstract:[This corrects the article DOI: 10.14218/JCTH.2021.00046.].

gastroenterology & hepatology
Erratum: Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells

Zixue Jin,Rui Sun,Wei H,Xiang Gao,Yongyan Chen,Zhigang Tian

DOI: https://doi.org/10.1002/hep.24135

IF: 17.298

2011-01-01

Hepatology

Abstract:In the January 2011 issue of HEPATOLOGY, in the article entitled “Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells” (HEPATOLOGY 201153:219–229), the unit of the y axis in Fig. 7A should have been 105, and Fig. 8C (left panel) was inadvertently substituted for Fig. 8B; the corrections do not change the conclusions or the results. The corrected versions of Figs. 7A and 8B are provided here.
Erratum: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

Frontiers Production Office

DOI: https://doi.org/10.3389/fpubh.2024.1400355

IF: 5.2

2024-04-11

Frontiers in Public Health

Abstract:This article is an erratum on: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

public, environmental & occupational health
Author Correction: Prevalence and Characteristics of Hypoxic Hepatitis in the Largest Single-Centre Cohort of Avian Influenza A(H7N9) Virus-Infected Patients with Severe Liver Impairment in the Intensive Care Unit

Yi Min Zhang,Ji Min Liu,Liang Yu,Ning Zhou,Wei Ding,Shu Zheng,Shilei Ding,Lan Juan Li

DOI: https://doi.org/10.1038/s41426-018-0054-9

2018-01-01

Emerging Microbes & Infections

Abstract:Correction to: Emerging Microbes & Infections (2016) 5:e1; https://doi.org/10.1038/emi.2016.1 ; Article published online 6 January 2016.
Erratum to: Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation

Xinhua Chen,Xueqin Meng,Yuning Xu,Haiyang Xie,Shengyong Yin,Hongchun Li,Liming Wu,Shusen Zheng

DOI: https://doi.org/10.1186/s40001-017-0275-8

IF: 4.981

2017-10-03

European Journal of Medical Research

Abstract:Following publication of the original article [1], the authors requested a correction in the presentation of their institutions as they appear on the Web of Science. Specifically, it should be emphasized that the institutions belong to Zhejiang University. The correct presentation of affiliations is given in this erratum.

medicine, research & experimental
Erratum: Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells

Xin-Dan Kang,Yong Zheng,Wei-Gang Chen,Min Cheng,Di Zhang

DOI: https://doi.org/10.3892/ol.2021.12552

Abstract:[This corrects the article DOI: 10.3892/ol.2017.7469.].
Erratum: Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369683

IF: 7.3

2024-01-26

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1094871.].

immunology
Correction To: Safety and Efficacy of Lamivudine or Telbivudine Started in Early Pregnancy for Mothers with Active Chronic Hepatitis B

Tianyu He,Yan Bai,Haodong Cai,Xiaojuan Ou,Liu M,Wei Yi,Jidong Jia

DOI: https://doi.org/10.1007/s12072-018-9876-8

IF: 9.029

2018-01-01

Hepatology International

Abstract:The aim of this erratum is to clearly state the individual author's contribution which was erroneously mentioned as "Tianyu He, Yuqing Bai, Wei Yi, and Jidong Jia contributed equally to this work."
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Lei Qian,Nanya Wang,Huimin Tian,Haofan Jin,Hengjun Zhao,Chao Niu,Hua He,Tingwen Ge,Wei Han,Jifan Hu,Dan Li,Fujun Han,Jianting Xu,Xiao Ding,Jingtao Chen,Wei Li,Jiuwei Cui

DOI: https://doi.org/10.1155/2022/9761463

IF: 4.4929

2022-07-18

Journal of Immunology Research

Abstract:In the article titled "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients" [1], the authors wish to correct Figure 2. Due to an oversight when preparing the manuscript, it is duplicated with Figure 3 in a previous publication by the authors [2]. These two studies were related, and the data were saved to the same location, contributing to the erroneous selection of the image for publication. The authors apologise for this error and provide the corrected Figure 2 as follows:

immunology
Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020

DOI: https://doi.org/10.1183/23120541.50555-2020

2021-12-06

Abstract:[This corrects the article DOI: 10.1183/23120541.00555-2020.].

Erratum: The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma

Erratum: Endoplasmic reticulum aminopeptidase 1 is involved in anti-viral immune response of hepatitis B virus by trimming hepatitis B core antigen to generate 9-mers peptides

Erratum: New insights into the role of macrophages in cancer immunotherapy

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum

Erratum: Approaching hemophagocytic lymphohistiocytosis

Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis

Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins

Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Erratum: Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

Corrigendum: Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease

Erratum: Accelerated Liver Fibrosis in Hepatitis B Virus Transgenic Mice: Involvement of Natural Killer T Cells

Erratum: Short- and long-term effects of radiation exposure at low dose and low dose rate in normal human VH10 fibroblasts

Author Correction: Prevalence and Characteristics of Hypoxic Hepatitis in the Largest Single-Centre Cohort of Avian Influenza A(H7N9) Virus-Infected Patients with Severe Liver Impairment in the Intensive Care Unit

Erratum to: Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation

Erratum: Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells

Erratum: Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

Correction To: Safety and Efficacy of Lamivudine or Telbivudine Started in Early Pregnancy for Mothers with Active Chronic Hepatitis B

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Erratum: "Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer". Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020